Form 4: Agilent Technologies Executive Robert McMahon Reports Stock and Option Transactions
SEC Form 4 Filing
Agilent Technologies' Senior VP and CFO, Robert McMahon, reported the acquisition of restricted stock units and stock options on November 27, 2024.
Summary
- Robert McMahon, Senior VP and CFO of Agilent Technologies, reported transactions involving company stock and options.
- On November 27, 2024, McMahon acquired 6,423 restricted stock units at a price of $138.14 per unit.
- These restricted stock units vest in four equal annual installments starting November 27, 2024, and have a one-year post-vest holding period.
- McMahon also acquired 18,544 employee stock options with an exercise price of $138.14.
- These options vest in four equal annual installments beginning on November 27, 2025, and expire on November 27, 2034.
- Following these transactions, McMahon beneficially owns 166,762.835 shares of common stock and 18,544 stock options.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.
Positives
- The acquisition of stock and options by a key executive like the CFO can be seen as a positive sign of confidence in the company's future performance.
- The vesting schedule of the restricted stock units and options aligns the executive's interests with the long-term success of the company.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of key executives and their alignment with shareholder interests.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard forms of executive compensation in the technology industry, used by companies like Thermo Fisher Scientific, Danaher, and Illumina.
- The vesting schedules and holding periods are typical for these types of grants, designed to incentivize long-term performance and retention.
- The reported transaction is similar to those seen in other SEC Form 4 filings from executives at comparable companies.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder sentiment, as they indicate executive confidence in the company.
- The vesting schedules of the stock and options align the executive's interests with the long-term success of the company, which is beneficial for shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/27/2024 | Date of the stock and option transactions, and the first vesting date for the restricted stock units. |
| 11/27/2025 | First vesting date for the employee stock options. |
| 11/27/2034 | Expiration date for the employee stock options. |
| 12/02/2024 | Date the form was signed by attorney-in-fact for Mr. McMahon. |
Keywords
Agilent Technologies, Robert McMahon, stock options, restricted stock units, insider trading, executive compensation, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.